https://doi.org/10.4081/monaldi.2025.3220
The impact of the COVID-19 pandemic on the profile of interstitial lung disease presenting to the pulmonary medicine department of a tertiary care center in western India
Submitted: October 10, 2024
Accepted: January 13, 2025
Published: March 20, 2025
Accepted: January 13, 2025
Abstract Views: 140
PDF_EARLY VIEW: 42
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
The COVID-19 pandemic impacted the etiological pattern of interstitial lung diseases (ILDs). This study aimed to analyze the profile of ILDs presenting to our department during the pandemic. Specifically, this cross-sectional observational study was conducted with the institute's ethics committee approval in the year 2021-2022. The clinical profile and history of COVID-19 illness in ILDs were noted. Data was analyzed in percentages and means. Of the 136 cases included, 85 (62.5%) were men and 51 (37.5%) women. The average age was 55.1±12.01 years. Cough and breathlessness were the predominant symptoms. A total of 20 (15%) participants gave a past history of COVID-19, of whom 2 (10%) had mild, 2 (10%) had moderate, and 16 (80%) had severe COVID-19 illness. Among them, 9 (45%) cases had pre-existing ILD. Thus, 11 (55%) had new-onset ILD attributed to severe COVID-19. This contributed to 8% of the ILD caseload. Predominant ILD patterns on high-resolution computed tomography thorax were usual interstitial pneumonia, hypersensitivity pneumonitis (HP), and non-specific interstitial pneumonia. The ILD diagnosis with multidisciplinary discussion was idiopathic interstitial pneumonitis in 44 cases, HP in 36, connective tissue disease-ILD in 35, post-COVID-19 ILD in 11, sarcoidosis in 8, and silicosis in 2. COVID-19 was attributed to only 8% of the caseload and was the fourth most common cause of ILD. Generally, ILD cases were younger patients and had severe disease.
European Centre for Disease Prevention and Control. Tuberculosis - annual epidemiological report for 2016. Available from: https://www.ecdc.europa.eu/en/publications-data/tuberculosis-annual-epidemiological-report-2016.
Udwadia ZF, Koul P, Luca R. Post-COVID lung fibrosis: the tsunami that will follow the earthquake. Lung India 2021;38:S41-7.
DOI: https://doi.org/10.4103/lungindia.lungindia_818_20
Wild JM, Porter JC, Molyneaux PL, et al. Understanding the burden of interstitial lung disease post-COVID-19: the UK Interstitial Lung Disease-Long COVID Study (UKILD-Long COVID). BMJ Open Respir Res 2021;8:e001049.
DOI: https://doi.org/10.1136/bmjresp-2021-001049
Stewart I, Jacob J, George PM. Residual lung abnormalities after COVID-19 hospitalization: interim analysis of the UKILD post–COVID-19 study. Am J Respir Crit Care Med 2022;207:647-9.
Das V, Desai U, Joshi JM. Clinical profile of interstitial lung disease at a tertiary care center, India. Pneumon 2017;30: 17-23.
Coultas DB. Zumwalt RE, Black WC, Sobonya RE. The epidemiology of interstitial lung diseases. Am J Respir Crit Care Med 1994; 150:967-72.
DOI: https://doi.org/10.1164/ajrccm.150.4.7921471
American Thoracic Society, European Respiratory Society. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 2002;165:277-304.
DOI: https://doi.org/10.1164/ajrccm.165.2.ats01
Antin-Ozerkis D, Rubinowitz A, Evans J, et al. Interstitial lung disease in the connective tissue diseases. Clin Chest Med 2012;33:123-49.
DOI: https://doi.org/10.1016/j.ccm.2012.01.004
Takeda A, Ishii Y. Interstitial pneumonia associated with connective tissue disease: an overview and an insight. In: Chroneos ZC, ed. Contemporary topics of pneumonia. London, UK: InTech; 2017.
DOI: https://doi.org/10.5772/intechopen.70864
Lamblin C, Bergoin C, Saelens T, Wallaert B. Interstitial lung diseases in collagen vascular diseases. Eur Respir J 2001;18:69s-80s.
DOI: https://doi.org/10.1183/09031936.01.18s320069
Molina-Molina M, Badia JR, Marín-Arguedas A, et al. Outcomes and clinical characteristics of patients with pulmonary fibrosis andrespiratory failure admitted to an intensive care unit. A study of 20 cases. Med Clin 2003;121:63-7.
DOI: https://doi.org/10.1157/13048922
Singh S, Collins BF, Sharma BB, et al Interstitial lung disease in India. Results of a prospective registry. Am J Respir Crit Care Med 2017;195:801-13.
DOI: https://doi.org/10.1164/rccm.201607-1484OC
AbouYoussef HA, Sabri YY, El Essawy AF, et al. Clinicoradiography and pulmonary functional assessment of patients with diffuse parenchymal lung diseases in al-fayoum governorate. Egyptian J Bronchology 2019;13:125-31.
DOI: https://doi.org/10.4103/ejb.ejb_40_18
Erbes R, Schaberg T, Loddenkemper R. Lung function tests in patients with idiopathic pulmonary fibrosis: are they helpful for predicting outcome? Chest 1997;111:51-7.
DOI: https://doi.org/10.1378/chest.111.1.51
Boros PW, Franczuk M, Wesolowski S. Value of spirometry in detecting volume restriction in interstitial lung disease patients. Respiration 2004;71:374-9.
DOI: https://doi.org/10.1159/000079642
Fukihara J, Kondoh Y. COVID-19 and interstitial lung diseases: a multifaceted look at the relationship between the two diseases. Respir Investig 2023;61:601-17.
DOI: https://doi.org/10.1016/j.resinv.2023.05.007
Mehta P, Rosas IO, Singer M. Understanding post-COVID-19 interstitial lung disease (ILD): a new fibroinflammatory disease entity. Intensive Care Med 2022;48:1803-6.
DOI: https://doi.org/10.1007/s00134-022-06877-w
Ethics Approval
Ethic approval number - PG Academic project number ECARP/2021/05.How to Cite
Desai, Unnati, Ketaki Utpat, and Aravind Raj. 2025. “The Impact of the COVID-19 Pandemic on the Profile of Interstitial Lung Disease Presenting to the Pulmonary Medicine Department of a Tertiary Care Center in Western India”. Monaldi Archives for Chest Disease, March. https://doi.org/10.4081/monaldi.2025.3220.
Copyright (c) 2025 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Similar Articles
- Federico Raimondi, Stefano Centanni, Fabrizio Luppi, Stefano Aliberti, Francesco Blasi, Paola Rogliani, Claudio Micheletto, Marco Contoli, Alessandro Sanduzzi Zamparelli, Marialuisa Bocchino, Paolo Busatto, Luca Novelli, Simone Pappacena, Luca Malandrino, Giorgio Lorini, Greta Carioli, Fabiano Di Marco, Respiratory rate-oxygenation index on the 3rd day is the best predictor of treatment failure in COVID-19 patients , Monaldi Archives for Chest Disease: Vol. 94 No. 4 (2024)
- Evgenia I. Kalamara, Evangelos T. Ballas, Georgia Pitsiou, Guergana Petrova, Pulmonary rehabilitation for cystic fibrosis: A narrative review of current literature , Monaldi Archives for Chest Disease: Vol. 91 No. 2 (2021)
- Diletta Innocenti, Chiara Castellani, Eleonora Masi, Valeria Galici, Letizia Macconi, Giovanni Taccetti, Can percussive intrapulmonary ventilation improve the efficacy of physiotherapy in children with cystic fibrosis? , Monaldi Archives for Chest Disease: Vol. 94 No. 1 (2024)
- Matteo Vigna, Piero Ceriana, Mara Santomassimo, Michele Vitacca, Mauro Maniscalco, Nicolino Ambrosino, Effects of pulmonary rehabilitation in survivors of severe acute respiratory syndrome coronavirus 2. Role of vaccination , Monaldi Archives for Chest Disease: Vol. 94 No. 3 (2024)
- Maria Teresa Manes, Manlio Gagliardi, Gianfranco Misuraca, Stefania Rossi, Mario Chiatto, Left ventricular geometric patterns and cardiac function in patients with chronic renal failure undergoing hemodialysis , Monaldi Archives for Chest Disease: Vol. 64 No. 1 (2005): Cardiac series
- Anna Brivio, Annalisa Orenti, Mauro Barbisan, Paolo Buonpensiero, Mirco Ros, Simone Gambazza, Home physiotherapists assisting follow-up treatment in cystic fibrosis: a multicenter observational study , Monaldi Archives for Chest Disease: Vol. 91 No. 2 (2021)
- S. Lampert, S. Pour Schahin, G.H. Wiest, E.G. Hahn, J.H. Ficker, Arthropathy and cutaneous manifestations in a 28-year-old patient with cystic fibrosis , Monaldi Archives for Chest Disease: Vol. 65 No. 2 (2006): Pulmonary series
- H.J.C. Bonestroo, M.G. Slieker, H.G.M. Arets, No positive effect of rhdnase on the pulmonary colonization in children with cystic fibrosis , Monaldi Archives for Chest Disease: Vol. 73 No. 1 (2010): Pulmonary series
- Sunny Kumar, Saurabh Mehra, Mrinal Sircar, Onkar Jha, Rajesh Gupta, Seema Sinha, Ravneet Kaur, Evaluation of the efficacy of convalescent plasma in moderate to severe COVID-19 during 2020-2021: a retrospective observational study , Monaldi Archives for Chest Disease: Early Access
- Megha Hegde, Saurav Raj, Dhananjay Tikadar, Sanatkumar B Nyamagoud, Unveiling vaccine safety: a narrative review of pharmacovigilance in India’s COVID-19 vaccination , Monaldi Archives for Chest Disease: Vol. 94 No. 4 (2024)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
You may also start an advanced similarity search for this article.
